Recombinant Human MGAT2 (C-6His)

Description

EnkiLife provides the Recombinant Human MGAT2 (C-6His) protein,aslo know as Alpha-1;6-Mannosyl-Glycoprotein 2-Beta-N-Acetylglucosaminyltransferase,Beta-1;2-N-acetylglucosaminyltransferase II,GlcNAc-T II,NT-II,Mannoside Acetylglucosaminyltransferase 2,N-Glycosyl-Oligosaccharide-Glycoprotein N-Acetylglucosaminyltransferase II,MGAT2, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Mannoside Acetylglucosaminyltransferase 2 is produced by our Mammalian expression system and the target gene encoding Arg30-Gln447 is expressed with a 6His tag at the C-terminus.Accession:Q10469. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:49.3 KDa. Background:Mannoside Acetylglucosaminyltransferase 2 (MGAT2) is a single-pass type II membrane protein that contains the typical glycosyltransferase domains: a short N-terminal cytoplasmic domain, a hydrophobic non-cleavable signal-anchor domain and a C-terminal catalytic domain. MGAT2 catalyzes an essential step in the conversion of oligo-mannose to complex N-glycans. Defects in MGAT2 are the cause of congenital disorder of glycosylation type 2A.